{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:06:23Z","timestamp":1793833583057,"version":"4.6.1"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ijsu.2022.106738","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T03:33:53Z","timestamp":1656646433000},"page":"106738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8014-3762","authenticated-orcid":false,"given":"Laura E.","family":"Gould","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Pring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1621-0323","authenticated-orcid":false,"given":"Ioanna","family":"Drami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Moorghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Naghibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin W.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Campbell SD.","family":"Roxburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"7","key":"10.1016\/j.ijsu.2022.106738_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/DCR.0000000000000839","article-title":"Pelvic exenteration surgery: the evolution of radical surgical techniques for advanced and recurrent pelvic malignancy","volume":"60","author":"Brown","year":"2017","journal-title":"Dis. Colon Rectum"},{"issue":"2","key":"10.1016\/j.ijsu.2022.106738_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/SLA.0000000000001963","article-title":"A systematic review to assess resection margin status after abdominoperineal excision and pelvic exenteration for rectal cancer","volume":"265","author":"Simillis","year":"2017","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.ijsu.2022.106738_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/DCR.0000000000000825","article-title":"The evolution of pelvic exenteration practice at a single center","volume":"60","author":"Koh","year":"2017","journal-title":"Dis. Colon Rectum"},{"issue":"13","key":"10.1016\/j.ijsu.2022.106738_bib4","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/cncr.29993","article-title":"Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: an analysis from the National Cancer Data Base","volume":"122","author":"Sineshaw","year":"2016","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ijsu.2022.106738_bib5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/bjs.9192","article-title":"Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes","volume":"100","year":"2013","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106738_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.seminoncol.2020.02.001","article-title":"Locally advanced rectal cancer: the past, present, and future","volume":"47","author":"Oronsky","year":"2020","journal-title":"Semin. Oncol."},{"issue":"8","key":"10.1016\/j.ijsu.2022.106738_bib7","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/bjs.11171","article-title":"Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer","volume":"106","author":"Zaborowski","year":"2019","journal-title":"BJS"},{"issue":"8","key":"10.1016\/j.ijsu.2022.106738_bib8","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","article-title":"Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial","volume":"16","author":"R\u00f6del","year":"2015","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.ijsu.2022.106738_bib9","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ijsu.2022.106738_bib10","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1200\/JCO.2010.33.1595","article-title":"Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of european randomized clinical trials","volume":"29","author":"Valentini","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"28","key":"10.1016\/j.ijsu.2022.106738_bib11","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"G\u00e9rard","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ijsu.2022.106738_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-2007-984870","article-title":"Management of locally advanced primary and recurrent rectal cancer","volume":"20","author":"de Wilt","year":"2007","journal-title":"Clin. Colon Rectal Surg."},{"issue":"10","key":"10.1016\/j.ijsu.2022.106738_bib13","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/bjs.6699","article-title":"Locally recurrent rectal cancer in Norway","volume":"96","author":"Hansen","year":"2009","journal-title":"Br. J. Surg."},{"issue":"4","key":"10.1016\/j.ijsu.2022.106738_bib14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.SLA.0000059972.90598.5F","article-title":"Curative potential of multimodality therapy for locally recurrent rectal cancer","volume":"237","author":"Hahnloser","year":"2003","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.ijsu.2022.106738_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1245\/s10434-006-9256-9","article-title":"A population-based study on the management and outcome in patients with locally recurrent rectal cancer","volume":"14","author":"Palmer","year":"2007","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ijsu.2022.106738_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijsu.2022.106738_bib17","author":"Royal College of Pathologists"},{"issue":"8","key":"10.1016\/j.ijsu.2022.106738_bib18","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.ejso.2021.03.258","article-title":"Pathology reporting of pelvic exenteration specimens for locally recurrent rectal cancer","volume":"47","author":"D\u00e4ster","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2022.106738_bib19","doi-asserted-by":"crossref","first-page":"k4597","DOI":"10.1136\/bmj.k4597","article-title":"A guide to systematic review and meta-analysis of prognostic factor studies","volume":"364","author":"Riley","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106738_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst. Rev."},{"key":"10.1016\/j.ijsu.2022.106738_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j4008","article-title":"Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ijsu.2022.106738_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/s10151-018-1883-1","article-title":"Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer","volume":"22","author":"Platt","year":"2018","journal-title":"Tech. Coloproctol."},{"issue":"4","key":"10.1016\/j.ijsu.2022.106738_bib23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106738_bib24","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-009-0737-5","article-title":"Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy","volume":"17","author":"Pacelli","year":"2010","journal-title":"Ann. Surg Oncol."},{"issue":"3","key":"10.1016\/j.ijsu.2022.106738_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2014.10.014","article-title":"Multivisceral resection for advanced rectal cancer: outcomes and experience at a single institution","volume":"209","author":"Crawshaw","year":"2015","journal-title":"Am. J. Surg."},{"issue":"6","key":"10.1016\/j.ijsu.2022.106738_bib26","doi-asserted-by":"crossref","DOI":"10.21873\/invivo.11723","article-title":"Pelvic exenteration for locally advanced and relapsed pelvic malignancies \u2013 an analysis of 100 cases","volume":"33","author":"Bacalbasa","year":"2019","journal-title":"In Vivo"},{"issue":"3","key":"10.1016\/j.ijsu.2022.106738_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ciresp.2014.07.009","article-title":"Exenteraci\u00f3n p\u00e9lvica total en el tratamiento de las neoplasias avanzadas, primarias o recurrentes, de v\u00edsceras p\u00e9lvicas","volume":"93","author":"Carballo","year":"2015","journal-title":"Cirug\u00eda Espa\u00f1ola"},{"key":"10.1016\/j.ijsu.2022.106738_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2017.05.037","article-title":"Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: a 9 year consecutive single-centre cohort study","author":"Katory","year":"2017","journal-title":"Int. J. Surg."},{"issue":"3","key":"10.1016\/j.ijsu.2022.106738_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s00423-021-02143-7","article-title":"Outcomes of exenteration in cT4 and fixed cT3 stage primary rectal adenocarcinoma: a subgroup analysis of consolidation chemotherapy following neoadjuvant concurrent chemoradiotherapy","volume":"406","author":"Kumar","year":"2021","journal-title":"Langenbeck's Arch. Surg."},{"key":"10.1016\/j.ijsu.2022.106738_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijsu.2017.09.069","article-title":"Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer","volume":"48","author":"Rottoli","year":"2017","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijsu.2022.106738_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/ans.14427","article-title":"Development of a pelvic exenteration service at a tertiary referral centre","author":"Dickfos","year":"2018","journal-title":"ANZ J. Surg."},{"issue":"13","key":"10.1016\/j.ijsu.2022.106738_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.11854","article-title":"International variation in managing locally advanced or recurrent rectal cancer: prospective benchmark analysis","volume":"107","author":"Denost","year":"2020","journal-title":"Br. J. Surg."},{"issue":"4","key":"10.1016\/j.ijsu.2022.106738_bib33","doi-asserted-by":"crossref","DOI":"10.1007\/s11605-013-2400-5","article-title":"Pelvic exenteration for the treatment of locally advanced colorectal and bladder malignancies in the modern era","volume":"18","author":"Speicher","year":"2014","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.ijsu.2022.106738_bib34","article-title":"A minimally invasive pelvic multivisceral resection approach for locally advanced primary colorectal cancers: a single-institution experience","author":"Lee","year":"2021","journal-title":"J. Laparoendosc. Adv. Surg. Tech."},{"issue":"4","key":"10.1016\/j.ijsu.2022.106738_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/codi.13517","article-title":"The selection process can improve the outcome in locally advanced and recurrent colorectal cancer: activity and results of a dedicated multidisciplinary colorectal cancer centre","volume":"19","author":"Kontovounisios","year":"2017","journal-title":"Colorectal Dis."},{"issue":"3","key":"10.1016\/j.ijsu.2022.106738_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s12029-014-9586-y","article-title":"Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer","volume":"45","author":"Xin","year":"2014","journal-title":"J. Gastrointest. Cancer"},{"issue":"3","key":"10.1016\/j.ijsu.2022.106738_bib37","article-title":"Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer","volume":"26","author":"Gawad","year":"2014","journal-title":"J. Egypt. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.ijsu.2022.106738_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.9841","article-title":"Determinants of survival following pelvic exenteration for primary rectal cancer","volume":"102","author":"Radwan","year":"2015","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106738_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.9683","article-title":"Survival after pelvic exenteration for T4 rectal cancer","volume":"102","author":"Kusters","year":"2015","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ijsu.2022.106738_bib40","article-title":"What constitutes a clear margin in patients with locally recurrent rectal cancer undergoing pelvic exenteration?","author":"Koh","year":"2020","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.ijsu.2022.106738_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0b013e31828a0d22","article-title":"Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer","volume":"259","author":"Bhangu","year":"2014","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.ijsu.2022.106738_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.asjsur.2011.08.002","article-title":"Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases","volume":"34","author":"Hsu","year":"2011","journal-title":"Asian J. Surg."},{"issue":"2","key":"10.1016\/j.ijsu.2022.106738_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2014.01.008","article-title":"Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 201","volume":"209","author":"Ghouti","year":"2015","journal-title":"Am. J. Surg."},{"issue":"45","key":"10.1016\/j.ijsu.2022.106738_bib44","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v24.i45.5144","article-title":"Pelvic exenterations for primary rectal cancer: analysis from a 10-year national prospective database","volume":"24","author":"Pellino","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.ijsu.2022.106738_bib45","doi-asserted-by":"crossref","DOI":"10.1503\/cjs.014010","article-title":"Total pelvic exenteration for rectal cancer: outcomes and prognostic factors","volume":"54","author":"Domes","year":"2011","journal-title":"Can. J. Surg."},{"issue":"5","key":"10.1016\/j.ijsu.2022.106738_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrab074","article-title":"Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes","volume":"5","author":"Kazi","year":"2021","journal-title":"BJS Open"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106738_bib47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00384-015-2353-0","article-title":"Layer-oriented total pelvic exenteration for locally advanced primary colorectal cancer","volume":"31","author":"Koda","year":"2016","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.ijsu.2022.106738_bib48","doi-asserted-by":"crossref","DOI":"10.4274\/tjcd.galenos.2020.2020-8-1","article-title":"Pelvic exenteration for recurrent rectal cancer: a single institution experience","volume":"31","author":"Culcu","year":"2021","journal-title":"Turkish Journal of Colorectal Disease"},{"issue":"2","key":"10.1016\/j.ijsu.2022.106738_bib49","article-title":"Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration","volume":"269","year":"2019","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.ijsu.2022.106738_bib50","article-title":"Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer","volume":"105","year":"2018","journal-title":"Br. J. Surg."},{"issue":"12","key":"10.1016\/j.ijsu.2022.106738_bib51","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/BF02660766","article-title":"Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer","volume":"46","author":"Jimenez","year":"2003","journal-title":"Dis. Colon Rectum"},{"issue":"3","key":"10.1016\/j.ijsu.2022.106738_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4174\/astr.2015.89.3.131","article-title":"Outcomes of pelvic exenteration for recurrent or primary locally advanced colorectal cancer","volume":"89","author":"Yang","year":"2015","journal-title":"Ann Surg Treat Res"},{"issue":"2","key":"10.1016\/j.ijsu.2022.106738_bib53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.surg.2008.09.014","article-title":"Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period","volume":"145","author":"Ishiguro","year":"2009","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.ijsu.2022.106738_bib54","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1463-1318.2011.02893.x","article-title":"A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database","volume":"14","author":"Nielsen","year":"2012","journal-title":"Colorectal Dis."},{"issue":"11","key":"10.1016\/j.ijsu.2022.106738_bib55","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma","volume":"73","author":"Mandard","year":"1994","journal-title":"Clinicopathologic correlations. Cancer"},{"issue":"4","key":"10.1016\/j.ijsu.2022.106738_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/bjs5.50153","article-title":"Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer","volume":"3","author":"PelvEx Collaborative","year":"2019","journal-title":"BJS Open"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106738_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16955-5","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis","volume":"7","author":"Dolan","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijsu.2022.106738_bib58","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/annonc\/mdt593","article-title":"The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer","volume":"25","author":"Park","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijsu.2022.106738_bib59","article-title":"biomarkers in locally advanced rectal cancer: a review","author":"Mendis","year":"2021","journal-title":"Clin. Colorectal Cancer"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919122005155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919122005155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T11:08:54Z","timestamp":1677064134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919122005155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":59,"alternative-id":["S1743919122005155"],"URL":"https:\/\/doi.org\/10.1016\/j.ijsu.2022.106738","relation":{},"ISSN":["1743-9191"],"issn-type":[{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijsu.2022.106738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106738"}}